|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-1.26/--
|
Enterprise Value
96.09M
|
Balance Sheet |
Book Value Per Share
0.39
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
12.67M
|
Operating Revenue Per Share
0.40
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/11/16 12:16 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications. |